U.K. expects first access on Oxford vaccine, rolls out antibody study

The U.K. will be “the first to get access” to the University of Oxford’s COVID-19 vaccine, Business Secretary Alok Sharma said Sunday, adding that 30 million doses will be available by September, when Oxford hopes to make the vaccine available for emergency use. The country also rolled out an antibody testing program to track COVID-19 infections and symptoms of 20,000 participants.

In a press briefing Sunday, Sharma said the U.K. will provide £84 million ($101.7 million) collectively to vaccine programs from the University of Oxford’s Jenner Institute and Imperial College London...